How many institutions held PVLA - PALVELLA THERAPEUTICS, INC. - Common Stock, $0.01 par value in Q3 2026?

22 institutional investors reported PVLA - PALVELLA THERAPEUTICS, INC. - Common Stock, $0.01 par value for Q3 2026. Use the holders table for investor-level position and value details.

PALVELLA THERAPEUTICS, INC. - Common Stock, $0.01 par value (PVLA)

Q: What does CUSIP 697947109 represent in this 13F holders report?

CUSIP 697947109 is the security identifier for PVLA - PALVELLA THERAPEUTICS, INC. - Common Stock, $0.01 par value used to aggregate holder disclosures.

CUSIP: 697947109

Q3 2026 13F Holders as of 30 Sep 2026

Security type / class: Equity / Common Stock, $0.01 par value
Total 13F shares: 135,999
Total 13F value: $18,758,146
Share change: +6,404
SEC-reported price per share: $137.93
Number of holders: 22
Value change: +$882,910
Number of buys: 10
Number of sells: 4
Shares outstanding: 14,402,940

Security key

697947109

Report period

Q3 2026

Institutions

Top holders

PVLA full security history Ownership snapshot Full 13F holder table PALVELLA THERAPEUTICS, INC. SEC filings PALVELLA THERAPEUTICS, INC. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 697947109

Recent filing periods:

Q3 2026

Ownership snapshot

Top reported holders of PVLA - PALVELLA THERAPEUTICS, INC. - Common Stock, $0.01 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

Kaupinen Wes

Disclosed value leader

MONTANOVA CAPITAL, LLC

Comparable rows

10/15

Latest evidence

30 Jun 2026

13D/G 3/4/5 13F Lead comparable stake: 15% 5 rows are not safely comparable across share classes. 13D/G row: Kaupinen Wes Showing 1-6 of 15 holder rows.

Quick read

Kaupinen Wes leads the comparable SEC ownership view at 15%.

10 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Kaupinen Wes's linked filing trail.

Comparable ownership Top 5

Kaupinen Wes 15%

MONTANOVA CAPITAL, LLC 7.4%

JENNISON ASSOCIATES LLC 6.7%

PRUDENTIAL FINANCIAL INC 6.7%

Frazier Life Sciences Public Fund... 6%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Kaupinen Wes	13D/G 3/4/5 President and CEO, Director, 10%+ Owner 13D/G 3/4/5	15% Reported 13D/G · 13 Dec 2024	$38,555,729 1,644,869 shares	$0	13 Dec 2024
MONTANOVA CAPITAL, LLC	13F 13D/G Company · SUVRETTA CAPITAL MANAGEMENT, LLC 13F 13D/G	7.4% Reported 13D/G · 30 Sep 2025	$173,512,745 1,135,406 shares	—	30 Jun 2026
JENNISON ASSOCIATES LLC	13F 13D/G Company 13F 13D/G	6.7% Reported 13D/G · 30 Jun 2026	$146,801,795 960,619 shares	—	30 Jun 2026
PRUDENTIAL FINANCIAL INC	13D/G 13D/G	6.7% Reported 13D/G · 30 Jun 2026	$140,535,475 962,374 shares	$0	30 Jun 2026
Frazier Life Sciences Public Fund, L.P.	13D/G 13D/G	6% Reported 13D/G · 31 Dec 2025	$70,982,116 706,360 shares	+$16,164,419	31 Dec 2025
BlackRock, Inc.	13F 13D/G Company 13F 13D/G	5.7% Reported 13D/G · 30 Jun 2026	$140,343,317 918,357 shares	—	30 Jun 2026

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

135,999

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2026 vs Q2 2026 Across Filers

Q2 2026 holders

195

Q3 2026 holders

Holder diff

-173

Investor	Q2 2026 Shares	Q3 2026 Shares	Share Diff	Share Chg %	Q2 2026 value	Q3 2026 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend